X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Copay assistance is a lifeline for patients. So why are insurers blocking it?

By Stephen J. Ubl  |    June 29, 2022
In today’s broken insurance system, patients too often pay more for a medicine than what their insurance company pays.   Read More

Patients support state action requiring PBMs and insurers to share savings and cap costs for medicines

By Stami Williams  |    June 16, 2022
Patient concerns over ever-increasing costs are growing, especially when it comes to their health care. Morning Consult recently conducted a 50-state poll of 20,000 Americans on behalf of PhRMA to...   Read More

New poll shows voters sounding the alarm on health insurance companies and PBMs

By Cynthia Hicks  |    June 6, 2022
Many Americans battle with an illness every day, but unfortunately for some, their illness is not the only battle they face. A recent Morning Consult/PhRMA poll of 2,004 registered voters shows that...   Read More

In comments to federal agency, PhRMA warns of the growing influence of middlemen over patient access and out-of-pocket costs for prescription medicines

By Brian Newell  |    May 31, 2022
In comments submitted to the Federal Trade Commission (FTC), PhRMA urged the agency to examine how pharmacy benefit managers (PBMs) leverage their extraordinary power to maximize profits, often in...   Read More

ICYMI: PhRMA COO Lori Reilly spotlights efforts to improve health care in 2022 and beyond

By Emilie Signora  |    May 9, 2022
The COVID-19 pandemic has made clear how important a stable health care system is to the American people, both during times of crisis and beyond. Patients deserve sustainable, patient-centered...   Read More

Study finds insurance barriers disproportionately burden patients with chronic illness

By Cynthia Hicks  |    May 4, 2022
A recent Patient Experience Survey found that Americans with serious chronic conditions, including autoimmune diseases, mental health conditions and neurologic conditions were more likely than all...   Read More

What’s really happening when it comes to prescription drug costs

By Katie Koziara  |    April 27, 2022
New data show how robust competition continues to keep national spending on life-saving medicines in check, even as new innovative treatments reach patients. According to the latest report by the...   Read More

5 public opinion polling trends to watch

By Tom Wilbur  |    April 22, 2022
Today, we’re taking a closer look at Americans’ leading concerns and what issues they want policymakers to prioritize.   Read More

New analysis confirms hospitals markup prices for oncology therapies

By Gabby Migliara  |    April 21, 2022
A recent study from The Journal of the American Medical Association (JAMA) examined 61 hospitals using data made public under new requirements from a recent price transparency regulation. The...   Read More

Analysis: States can help patients save nearly $1,000 annually on their medicines

By Reid Porter  |    April 21, 2022
According to a new Ipsos/PhRMA poll, most Americans — 82% — agree that lowering out-of-pocket costs for health care should be a top priority for policymakers. A good place to start in lowering these...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates